Hi, I have 1.5 years of er experience at another mm firm and I was wondering if anyone here knew anything about these firms in terms of comp, lifestyle/culture,hours, experience, exit ops to the buyside, size, sales force size etc. (specifcally the healthcare group for a research associate) thanks
| +72 | Q&A - Buyside Equity Research Analyst/PM | 27 | 1w | |
| +31 | How the heck do you learn all of this stuff? | 5 | 4d | |
| +28 | Getting Frustrated | 10 | 3w | |
| +27 | My experience on the sell side | 20 | 1w | |
| +22 | What’s my next move? | 6 | 2w | |
| +18 | Biotech ER vs IB | 16 | 3w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 1w | |
| +14 | Am i fairly compensated? | 7 | 15h | |
| +14 | Data Science to PM | 8 | 1d | |
| +13 | ER time line and ways to break in help | 17 | 3w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Don't know anything about comp/hours/work-life etc. but I do know that Jefferies probably has some of the best healthcare research reports. GS is also up there, with DB and CS slightly below (though there have been a couple of awful CS reports).
as far as the street is concerned, wachovia and jefferies are basically the same tier. what you should really be thinking about is the quality of the analyst you will be working with, as well as how much visibility you will be getting. if you already work in research, you must already understand how much of your experience will be shaped by the analyst.
also, for what it's worth, i know healthcare research well and it's pretty easy to guess who you'd be working with at each firm....and my sense is the analyst at wachovia seems to have more street cred than the ones at jefferies. in fact, one of the jefferies analysts got canned about a year ago for violating firm policy, doing something pretty ridiculous like trying to pump his own calls or by spreading rumors about stocks under coverage in order to generate trade commissions, or something to that effect. i can't remember what happened for sure but people "in the know" didn't seem particularly surprised.
Fair enough. I was pretty impressed by the level of depth and understanding on a few of the Jefferies managed care reports- too often most managed care analyst reports devolve into spewing of projections and discussing the sensitivities of MLR. Pharma was a little shaky, the dude didn't really seem to understand pipeline dynamics/reasonable estimates for FDA approval.
Jefferies is one the best research department in the street specifically for the internet software department.
Harum aut autem vel mollitia repellendus ratione rerum. Quas autem quo fugiat ad eum voluptatem. Consequuntur doloremque sed est libero aut magni. Qui ut numquam voluptatem debitis et doloribus eos aperiam. Ratione et et corrupti aliquid.
Dignissimos voluptas non et corrupti aut porro voluptate. Totam tempore et in eos ut deleniti. Numquam exercitationem placeat occaecati. Voluptates incidunt voluptates nemo aspernatur rem mollitia rerum et. Sapiente culpa commodi in dolorum sint.
Voluptates quod ad cupiditate ut nemo. Suscipit rerum pariatur corrupti doloribus quia sed recusandae enim. Eum enim et aperiam repellat et aut. Eos ab commodi minus blanditiis dolorem ipsum quos. Dolorem assumenda qui fugit aut commodi voluptatem.
Vitae illum expedita eos ipsa id quaerat. Voluptatem sint hic quas repellendus voluptatibus rerum. Sed inventore quaerat iste voluptas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...